Dr Seeds MOTS-c is a research-grade peptide sold for lab study. Learn about its mechanism, research dosages, safety, and comparison with other peptides.
Dr. Seeds MOTS-c is a research-grade peptide sold strictly for laboratory use. It is not a dietary supplement, medication, or FDA-approved product for human consumption. MOTS-c is a mitochondrial-derived peptide that researchers study for its potential role in metabolic regulation and cellular stress responses.
What Is Dr. Seeds MOTS-c?
MOTS-c is a 16-amino-acid peptide encoded in the mitochondrial genome. Dr. Seeds is a vendor that supplies this peptide as a lyophilized powder for in vitro and animal research. The product is labeled "for research use only" and is not intended for human or veterinary use.
Unlike hormones or traditional drugs, MOTS-c is not synthesized by the body in large amounts. It is produced in mitochondria and can travel to the nucleus, where it influences gene expression. Scientists are still mapping its exact functions.
MOTS-c was first identified in 2015 by researchers studying mitochondrial communication. Since then, it has become a popular subject in aging and metabolism research. However, it remains an experimental compound.
How MOTS-c Works and Its Potential Benefits
In preclinical studies, MOTS-c has been shown to activate AMPK, a key enzyme in energy sensing. This activation may influence glucose uptake, fatty acid oxidation, and mitochondrial function. Researchers also investigate MOTS-c as an exercise mimetic because its levels rise after physical activity.
Proposed mechanisms from laboratory work include:
- Activation of the AMPK pathway in skeletal muscle and liver cells.
- Regulation of the folate-methionine cycle and antioxidant defenses.
- Modulation of inflammatory signaling in aged tissues.
These mechanisms are based on cell culture and rodent experiments. No human clinical trials have established a clear mechanism of action for MOTS-c.
The potential mots-c benefits that scientists are exploring include improved insulin sensitivity, reduced fat mass, and enhanced physical endurance. These findings come primarily from animal and cell culture studies. No large-scale human trials have confirmed any clinical benefit.
For example, a 2015 study in mice found that MOTS-c injections improved glucose tolerance and insulin sensitivity. Another study suggested that MOTS-c levels decline with age, which has led to interest in its role in aging research. However, these results do not prove that MOTS-c supplements help humans.
MOTS-c Dosage and Research Protocols
There is no established human dosage for MOTS-c. A mots-c dosage chart for research purposes typically lists doses used in animal studies, not human recommendations. For example, rodent studies often use 15 mg/kg intraperitoneal injections, but these amounts do not translate directly to humans.
The table below shows representative research dosages from published studies. These are not human dosages and should never be used for self-administration.
| Species | Route | Dose | Frequency | Research Focus |
|---|---|---|---|---|
| Mice | Intraperitoneal | 15 mg/kg | Daily | Metabolic regulation |
| Mice | Subcutaneous | 5 mg/kg | Every other day | Insulin sensitivity |
| Cell culture | In vitro | 10–50 µM | Single exposure | AMPK activation |
Researchers who order MOTS-c from Dr. Seeds must reconstitute the powder with bacteriostatic water or a suitable solvent. The dr seeds mots-c protocol often involves storing the peptide at -20°C and protecting it from light. Always follow the vendor's certificate of analysis for purity and handling instructions.
It is also important to use sterile technique in laboratory settings. Contamination can ruin experiments and introduce confounders. For human use, there is no safe dosage because the peptide has not been tested in clinical trials.
Comparing MOTS-c with AOD-9604, Tesamorelin, and SS-31
When researchers consider metabolic peptides, they often compare aod 9604 vs mots-c. AOD-9604 is a fragment of human growth hormone studied for fat metabolism, while MOTS-c targets mitochondrial energy regulation. Some protocols also examine how AOD-9604 and MOTS-c might affect lipid and glucose pathways when used together.
Another peptide, tesamorelin, is FDA-approved for a specific condition (HIV-associated lipodystrophy), unlike MOTS-c. The table below compares these three peptides in a research context.
| Peptide | Primary Research Focus | Mechanism | FDA Status |
|---|---|---|---|
| MOTS-c | Metabolic regulation | AMPK activation | Not approved |
| AOD-9604 | Fat metabolism | Lipolysis stimulation | Not approved |
| Tesamorelin | Visceral fat reduction | GHRH analog | Approved for HIV lipodystrophy |
Some mitochondrial researchers explore an ss-31 and mots-c protocol to study how these peptides interact. SS-31 (elamipretide) targets cardiolipin in the inner mitochondrial membrane, while MOTS-c influences nuclear gene expression. Combining them is speculative and not supported by human data.
Researchers may also study an AOD-9604, MOTS-c, and tesamorelin stack in animal models. There is no human data on the safety or efficacy of such a combination. Dosage information for that stack is purely speculative.
Safety, Legal Status, and Buying MOTS-c
MOTS-c is not FDA-approved for human use in the United States. Dr. Seeds sells it strictly as a research chemical. Injecting research peptides can cause unknown side effects, including immune reactions or hormonal disruption. Anyone considering peptide therapy should consult a licensed healthcare professional.
Research peptides are not regulated for human consumption. The FDA has issued warnings about unapproved peptides sold online. Buying from a vendor does not make a product safe or legal for personal use.
Dr. Seeds is one of several vendors offering MOTS-c. Researchers should look for third-party certificates of analysis (COA) and high-performance liquid chromatography (HPLC) purity data. A reputable vendor will provide batch-specific testing results.
Always verify that the product is labeled for research use only. Do not purchase MOTS-c for personal injection or consumption. If you have questions about peptide research, consult a qualified professional.
In summary, Dr. Seeds MOTS-c is a laboratory tool, not a therapeutic product. Its potential benefits remain unproven in humans, and its safety profile is unknown. Researchers should follow ethical guidelines and avoid any human use.
Frequently Asked Questions
Is Dr. Seeds MOTS-c safe for human use?
No. Dr. Seeds MOTS-c is sold for research purposes only and is not FDA-approved for human use. There are no clinical trials establishing its safety or side effect profile in people. Injecting research peptides carries unknown risks.
What is the typical MOTS-c dosage for research?
There is no standard human dosage. In animal studies, researchers have used doses like 15 mg/kg intraperitoneally in mice. These doses are not directly translatable to humans, and self-administration is dangerous.
Can MOTS-c be stacked with AOD-9604 or SS-31?
In laboratory research, some protocols combine MOTS-c with AOD-9604 or SS-31 to study metabolic and mitochondrial pathways. However, no human trials have tested these combinations. The safety and efficacy of such stacks are unknown.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.